A Dose-escalation Study of LPM3480392 in Chinese Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

November 2, 2021

Study Completion Date

November 2, 2021

Conditions

Healthy

Interventions

DRUG

LPM3480392

Intravenous infusion of 30min duration

DRUG

Placebo

Intravenous infusion of 30min duration

Trial Locations (1)

The second affiliated hosipital zhejiang university school of medicine, Hangzhou

All Listed Sponsors

lead

Luye Pharma Group Ltd.

INDUSTRY

NCT05862974 - A Dose-escalation Study of LPM3480392 in Chinese Healthy Subjects | Biotech Hunter | Biotech Hunter